Connor Iapoce

Data show HDP occurred in 7.4% of pregnancies in France during the study period.

The device is designed to assist in diagnosis to provide early intervention and appropriate care.

Data show 57.7% of patients achieved ≥20% improvement in joint symptoms and 53.4% achieved complete skin clearance at 1 year.

Positive detection rate for FH through next-generation sequencing was 27.0%, compared to 8.4% using 24-variant array based test.

Data show low BMI, male gender, and older age in patients associated with higher overall mortality.

An expert discussion on categorizing climate change and the impact it will have on health in communities across the globe.

The EMDAC voted 10-7 to support the benefit-risks of teplizumab for delaying clinical type 1 diabetes.

Weekly number of opioid-related deaths increased 135% over study period.

Nearly two-thirds of patients had improved or resolved EIM after ustekinumab treatment.

Patients with opioid-induced constipation had more frequent, painful constipation symptoms, compared to those with chronic idiopathic constipation.

Data show patients with IBD and pathogen produced a unique pathogen-specific microbiome.

Sucrase isomaltase deficiency is often overlooked symptom in adult patients with IBS-D.

Data show nearly 1 in 10 patients with IBS-D in study were identified with SID.

Data show adverse events occurred in 6.67% in the cohort of patients with IBD.

Data show adverse outcomes include increased mortality rates, prolonged hospital stay, and higher hospitalization chargers.

Data show global burden of NAFLD increased, while burden of cirrhosis decreased in adolescents and young adults.

Data show males, patients with high BMI correlated with higher FAST score in HCV care.

Data show clinically meaningful improvement in IBDQ score and MCS score in patients treated with UST.

Data show a 23.5% increase in influenza vaccination rates.

Data show biologic therapy was not associated with ICU admission or death due to infection.

Hospitalizations were more likely in patients with CDI of small bowel and Crohn's disease, with worse outcomes noted in patients admitted to ICU.

Patients treated with ruxolitnib cream show ≥75% improvement in facial vitiligo scoring index.

A daily opioid dose higher than 90 MME is associated with 3-fold risk increase, compared to 90 MME or lower.

An expert discussion on climate change and air pollution effects on communities, including increased COVID-19 rates.

Incidence rates decreased by nearly half after direct-acting antiviral treatment regimen.

Data show sublingual sufentanil tablets did not affect pain scores, but did benefit patient satisfaction outcomes.

The single 1000 mg dose treats iron deficiency anemia in adult patients.

Data show a nearly 30% reduction in individuals filling naloxone prescriptions at the start of COVID-19 pandemic, with no significant recovery observed.

The low-dose cohort of RP-A501 conferred cardiac LAMP2B transgene expression.

The treatment shows superior results over bupivacine solution, with a significant number of patients becoming opioid-free.